Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Satyamitra Kemas Lestari Tbk. (SMKL) Price & Performance

Brigit Biofarmaka Teknologi Tbk.Trade
Satyamitra Kemas Lestari Tbk.Trade

Price performance (Past 24H)

Key statistics

Brigit Biofarmaka Teknologi Tbk. vs Satyamitra Kemas Lestari Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Satyamitra Kemas Lestari Tbk. trades at Rp153 (market cap 536.64B, 92.3K 24h volume). The key difference: Satyamitra Kemas Lestari Tbk. is far larger — about 3.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (324K versus 92.3K). Which is the better fit depends on your goals.

OBATSMKL
Market Cap
166.01B536.64B
Volume
324K92.3K
Lot
3.24K923
Turnover
77.68M14.17M
Average Price
239.75153.5
Value
77.68M14.17M
Indicative Equilibrium Price
240153
Indicative Equilibrium Volume
1318

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

OBAT
View details
SMKL
View details

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT

About Satyamitra Kemas Lestari Tbk.

PT Satyamitra Kemas Lestari Tbk (The Company) was established based on Deed of Establishment No. 12 dated July 26, 2001 which was made in the presence of Juniaty Tedjaputra, S.H., a notary in Tangerang.

Read more on SMKL